Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Test of Behavioral Intervention for Women at High Risk for HIV Infection Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on A Test of Behavioral Intervention for Women at High Risk for HIV Infection conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A Test of Behavioral Intervention for Women at High Risk for HIV Infection Clinical research trials and A Test of Behavioral Intervention for Women at High Risk for HIV Infection healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including A Test of Behavioral Intervention for Women at High Risk for HIV Infection. A Test of Behavioral Intervention for Women at High Risk for HIV Infection Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a A Test of Behavioral Intervention for Women at High Risk for HIV Infection clinical trial. Participants typically obtain the most effective healthcare available for their A Test of Behavioral Intervention for Women at High Risk for HIV Infection condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > A Test of Behavioral Intervention for Women at High Risk for HIV Infection

A Test of Behavioral Intervention for Women at High Risk for HIV Infection



A Test of Behavioral Intervention for Women at High Risk for HIV Infection

For Condition: HIV Infections
Status: No longer recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: The purpose of this study is to find out if it is possible to conduct a group counseling program for women at risk for HIV infection. Women have been the fastest-growing group with new AIDS diagnoses. The need for ways to reduce HIV infection in women is urgent. It is important to reduce the risk of HIV infection through sexual contact, but it is also important to address drug use. Group counseling may be an effective method.
Details: Women have constituted the fastest-growing group of persons with new AIDS diagnoses for several years. The need to develop and evaluate interventions to reduce the incidence of HIV infection among women is urgent. The behavioral intervention method tested in this study integrates elements from diverse theories and empirical evidence for women to feel empowered to use methods of protection against disease. Although the overall objective of the study intervention is to reduce the risk of HIV infection through sexual contact, the intervention must also address drug usage among women. Women are randomized in a 1 to 1 ratio to either the intervention or control condition. The Intervention Group participates in 4 group sessions over the course of 1 month and then in an additional reunion session approximately 1 month after the 4th group session. Sessions are 2.5 hours long and include 6 to 10 participants. The sessions involve talking about HIV, ways to avoid HIV, and ways women can support each other. All participants complete a short-term assessment visit 1 week after the 4th group intervention session. The Control Group does not participate in group sessions. All participants are paid for their time and effort.
Eligibility:
Study Type:  Observational, Natural History
Minimum Age/Maximum Age: 18 Years/
Genders: Female
Protocol Entry Criteria: Inclusion Criteria Women may be eligible for this study if they: - Are at least 18 years old. - Took part in the VPS2 study and completed 12 months of follow-up, or each participant must meet at least 1 of the following conditions: 1) has sex with an HIV-infected male; 2) has sex with a male who has injected drugs in the last 5 years; 3) has had sex with 5 or more male partners in the last year; 4) exchanged sex for money or drugs in the last year; 5) was diagnosed with syphilis, chlamydia, gonorrhea, first episode herpes, pelvic inflammatory disease, and/or trichomonas in the last year; or 6) used crack cocaine in the last year. - Can speak English. - Can give information for the purpose of locating. - Have had at least 30 percent of vaginal or anal intercourse unprotected by condoms in the 6 months before the study. - Are HIV-negative. Exclusion Criteria Women will not be eligible for this study if they: - Have had sex with only 1 man for 2 years or more who is HIV-negative and does not inject drugs. The man should not have had sex with anyone else during this time. - Have a mental condition that would interfere with the study. - Have any other condition that would interfere with the study.
Total Enrollment: 180

Location and Contact Information:

Overall Study Official:
EricaGollub,  Study Chair, 

Anne Colletti
Cambridge,  Massachusetts,  02138
United States
 


Additional Information:
Study ID Numbers:  HIVNET 029; 
Study Start Date: March 2000
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006440

Other Hiv Infections Studies:
1. Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents

2. A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

3. Retrovirus Epidemiology Donor Study I (REDS I)

4. A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients

5. The Effects of Anti-HIV Therapy on the Immune Systems of Children Infected With HIV

Related Studies:

Other HIV Infections Clinical Trials
Other Massachusetts Clinical Trials
Other Cambridge Clinical Trials

A Test of Behavioral Intervention for Women at High Risk for HIV Infection
Modify your Search

  Other HIV Infections Clinical Trials
  Other Massachusetts Clinical Trials
  Other Cambridge Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103